RFG
BMY icon

REAP Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

REAP Financial Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Sell
916
-69
-7% -$3.96K 0.01% 294
2026
Q1 		$59.7K Buy
985
+106
+12% +$6.18K 0.01% 268
2025
Q4 		$47.4K Buy
879
+182
+26% +$8.76K 0.01% 306
2025
Q3 		$31.4K Buy
697
+58
+9% +$2.71K 0.01% 315
2025
Q2 		$29.6K Buy
639
+428
+203% +$21K 0.01% 319
2025
Q1 		$12.9K Buy
211
+54
+34% +$3.15K ﹤0.01% 347
2024
Q4 		$8.88K Buy
157
+146
+1,327% +$8.16K ﹤0.01% 379
2024
Q3 		$579 Hold
11
– – ﹤0.01% 559
2024
Q2 		$459 Sell
11
-141
-93% -$6.31K ﹤0.01% 516
2024
Q1 		$8.24K Buy
152
+141
+1,282% +$7.18K ﹤0.01% 393
2023
Q4 		$553 Buy
+11
New +$577 ﹤0.01% 620

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

REAP Financial Group's BMY Position: Q2 2026 in Review

REAP Financial Group reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q2 2026, selling an estimated $3.96K and leaving 916 shares worth $52.8K. The position accounts for 0.01% of the portfolio, ranked #294.

REAP Financial Group first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $59.7K in Q1 2026. 2,526 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • REAP Financial Group held 916 shares of Bristol-Myers Squibb worth $52.8K as of Q2 2026.
  • REAP Financial Group sold 69 Bristol-Myers Squibb shares in Q2 2026, an estimated $3.96K.
  • Bristol-Myers Squibb made up 0.01% of REAP Financial Group's portfolio in Q2 2026, its #294 holding.
  • REAP Financial Group first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
  • REAP Financial Group's Bristol-Myers Squibb position peaked at $59.7K in Q1 2026.
  • 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on REAP Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.